Parit-D Capsules.

Composition of Parit-D Capsules.

Parit-D Capsules. contains Paritaprevir 75 mg + Ritonavir 50 mg (per capsule). It belongs to the HCV NS3/4A protease inhibitor + pharmacokinetic enhancer (CYP3A inhibitor) class of medicines.

Uses of Parit-D Capsules.

Treatment of chronic hepatitis C virus (HCV) infection (used in combination with other antivirals as per genotype and doctor’s prescription).

Key benefits

• Helps suppress hepatitis C virus replication
• Improves chances of sustained virologic response when used in combination
• Reduces liver inflammation and progression to cirrhosis
• Oral once/twice daily regimen as prescribed

How Parit-D Capsules. works

Paritaprevir is an HCV NS3/4A protease inhibitor that blocks viral polyprotein processing and replication. Ritonavir acts mainly as a pharmacokinetic booster by inhibiting CYP3A4, increasing paritaprevir levels and effectiveness.

How to take Parit-D Capsules.

Take orally as prescribed by your doctor, usually with food. Swallow the capsule whole with water; do not crush or open. Take at the same time each day and complete the full course; do not stop without medical advice.

Take it exactly as your doctor prescribed. Do not change the dose or stop early on your own.

Missed dose and overdose

If you miss a dose

Take it as soon as you remember. If your next dose is almost due, skip the one you missed — never take two doses together to catch up.

If you take too much

An overdose of this medicine can cause confusion, kidney injury and fits. Do not wait for symptoms to appear — go to the nearest emergency department and take the pack or strip with you.

Side effects of Parit-D Capsules.

Most side effects of Parit-D Capsules. are mild and settle as the body adjusts. Reported side effects include:

• Nausea
• diarrhoea
• headache
• fatigue
• insomnia
• itching
• rash
• raised liver enzymes

Stop the medicine and seek help immediately for a rash, swelling of the face or lips, wheezing or difficulty breathing. Tell your doctor about any side effect that persists or worries you.

Safety advice for Parit-D Capsules.

Warnings and precautions

Prescription-only antiviral; use only under specialist supervision. Not recommended in severe hepatic impairment; monitor liver function before and during treatment. Risk of hepatitis B reactivation—HBV screening recommended before starting. Numerous clinically significant drug interactions due to ritonavir; do not start/stop other medicines without medical advice. Seek help for jaundice, dark urine, severe abdominal pain, persistent vomiting, severe rash or breathing difficulty.

Do not take Parit-D Capsules. if

Not for anyone with a known allergy to this medicine or to any ingredient in the pack.

Interactions with other medicines

Strong interactions with CYP3A substrates/inducers: rifampicin, carbamazepine, phenytoin, phenobarbital, St John’s wort (reduce effect/contraindicated); simvastatin/lovastatin (contraindicated), certain antiarrhythmics (e.g., amiodarone), sedatives (midazolam/triazolam), ergot derivatives, some antiretrovirals, immunosuppressants (tacrolimus/cyclosporine), anticoagulants (warfarin/DOACs—monitor), oral contraceptives containing ethinyl estradiol (avoid/alternative contraception).

How to store Parit-D Capsules.

Store below 25°C in a dry place, protected from light and moisture. Keep in original pack and out of reach of children.

Expert advice for Parit-D Capsules.

Start as early as your doctor advises. Keep well hydrated through the course.

Manufacturer and class

Manufacturer:

EISAI INDIA PVT LTD

Therapeutic class:

Antiviral (Anti-hepatitis C)

Drug class:

HCV NS3/4A protease inhibitor + pharmacokinetic enhancer (CYP3A inhibitor)